Literature DB >> 14980298

Microbiology of early CF lung disease.

Lisa Saiman1.   

Abstract

Recent bronchoscopy studies using assays to measure inflammation and molecular typing techniques have facilitated an increased understanding of the early events that occur within the lungs of young children with cystic fibrosis and provided additional insights into the natural history of lung disease in children. In 2000, the US CF National Patient Registry data showed that among 1000 infants <2 years of age, the first bacterial pathogens detected are Haemophilus influenzae, Staphylococcus aureus, and Pseudomonas aeruginosa and the prevalence of these pathogens in these young infants are 19%, 42%, and 29%, respectively. In addition, 7% harbour Stenotrophomonas maltophilia and <1% harbour Burkholderia cepacia complex. Several investigators have performed bronchoscopy studies on young infants to further examine the natural history of lung disease. In one such study of 40 CF infants, 65%, 63% and 70% of children at 1, 2, and 3 years of age harboured at least one CF pathogen. H. influenzae was most common (38%) in infants at 1 year of age, and S. aureus was most common in 2 (37%) and 3 (36%) year olds. P. aeruginosa increased from 18% at 1 year of age to 33% at 3 years of age and was usually present in high numbers, i.e., > or =10(5) CFU/ml of BAL fluid. Investigators have studied the microbiology of young CF infants using specimens derived from the upper airway (deep throat) compared with the lower airway (broncheoalveolar lavage specimens) to determine if the upper airway is predictive of pathogens in the lower airway. In general, these studies have shown that a negative oropharyngeal culture indicated that isolation of P. aeruginosa from the lower airway was unlikely, but a positive culture did not predict lower airway infection. Similar findings were noted for H. influenzae and S. aureus.

Entities:  

Mesh:

Year:  2004        PMID: 14980298     DOI: 10.1016/s1526-0542(04)90065-6

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  24 in total

Review 1.  Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.

Authors:  Thomas Bjarnsholt; Michael Givskov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

2.  True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.

Authors:  Vibeke B Rudkjøbing; Trine R Thomsen; Morten Alhede; Kasper N Kragh; Per H Nielsen; Ulla R Johansen; Michael Givskov; Niels Høiby; Thomas Bjarnsholt
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

3.  A novel zinc binding system, ZevAB, is critical for survival of nontypeable Haemophilus influenzae in a murine lung infection model.

Authors:  Charles V Rosadini; Jeffrey D Gawronski; Daniel Raimunda; José M Argüello; Brian J Akerley
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  High relatedness selects against hypermutability in bacterial metapopulations.

Authors:  Freya Harrison; Angus Buckling
Journal:  Proc Biol Sci       Date:  2007-05-22       Impact factor: 5.349

5.  Cystic fibrosis: the conductance regulator, ceramides, and possible treatments.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2017-10       Impact factor: 4.599

6.  Laboratory Diagnosis and Characterization of Fungal Disease in Patients with Cystic Fibrosis (CF): A Survey of Current UK Practice in a Cohort of Clinical Microbiology Laboratories.

Authors:  Maeve Boyle; John E Moore; Joanna L Whitehouse; Diana Bilton; Damian G Downey
Journal:  Mycopathologia       Date:  2018-03-02       Impact factor: 2.574

7.  Tracking humoral responses using self assembling protein microarrays.

Authors:  Niroshan Ramachandran; Karen S Anderson; Jacob V Raphael; Eugenie Hainsworth; Sahar Sibani; Wagner R Montor; Marcin Pacek; Jessica Wong; Mariam Eljanne; Martin G Sanda; Yanhui Hu; Tanya Logvinenko; Joshua Labaer
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

8.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

9.  Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays.

Authors:  Wagner R Montor; Jin Huang; Yanhui Hu; Eugenie Hainsworth; Susan Lynch; Jeannine-Weiner Kronish; Claudia L Ordonez; Tanya Logvinenko; Stephen Lory; Joshua LaBaer
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

Review 10.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.